Search research articles
Contact Us
Filters
Showing results (1-10 of 162) with videos related to
Page
of 17
Sort By:
Drugs
|
September 22, 2007
Translating efficacy into effectiveness in antiretroviral therapy: beyond the pill count
Courtney V Fletcher
Seminars in Pediatric Infectious Diseases
|
January 16, 2004
Pharmacology considerations for antiretroviral therapy in human immunodeficiency virus (HIV)-infected children
Dorie W Hoody, Courtney V Fletcher
Current HIV/AIDS Reports
|
August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitors
Peter L Anderson, Courtney V Fletcher
Current Infectious Disease Reports
|
July 27, 2001
Clinical Pharmacologic Considerations for HIV-1 Protease Inhibitors
Peter L. Anderson, Courtney V. Fletcher
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 5, 2005
Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS
Tom Delahunty, Lane Bushman, Courtney V Fletcher
Journal of Pharmacokinetics and Pharmacodynamics
|
October 27, 2007
Impact of censoring data below an arbitrary quantification limit on structural model misspecification
Wonkyung Byon, Courtney V Fletcher, Richard C Brundage
Antimicrobial Agents and Chemotherapy
|
October 23, 2013
Pharmacometric characterization of efavirenz developmental pharmacokinetics and pharmacogenetics in HIV-infected children
Ahmed Hamed Salem, Courtney V Fletcher, Richard C Brundage
Clinical Pharmacokinetics
|
June 19, 2016
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors
Anthony T Podany, Kimberly K Scarsi, Courtney V Fletcher
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 5, 2009
The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards
Tom Delahunty, Lane Bushman, Brian Robbins, et al.
CNS Drugs
|
August 3, 2002
Clinical implications of CNS penetration of antiretroviral drugs
Heather E Wynn, Richard C Brundage, Courtney V Fletcher
Page
of 17
Search research articles
Search
Showing results (1-10 of 162) with videos related to
Sort By:
Page
of 17
Drugs
|
September 22, 2007
Translating efficacy into effectiveness in antiretroviral therapy: beyond the pill count
Courtney V Fletcher
Seminars in Pediatric Infectious Diseases
|
January 16, 2004
Pharmacology considerations for antiretroviral therapy in human immunodeficiency virus (HIV)-infected children
Dorie W Hoody, Courtney V Fletcher
Current HIV/AIDS Reports
|
August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitors
Peter L Anderson, Courtney V Fletcher
Current Infectious Disease Reports
|
July 27, 2001
Clinical Pharmacologic Considerations for HIV-1 Protease Inhibitors
Peter L. Anderson, Courtney V. Fletcher
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 5, 2005
Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS
Tom Delahunty, Lane Bushman, Courtney V Fletcher
Journal of Pharmacokinetics and Pharmacodynamics
|
October 27, 2007
Impact of censoring data below an arbitrary quantification limit on structural model misspecification
Wonkyung Byon, Courtney V Fletcher, Richard C Brundage
Antimicrobial Agents and Chemotherapy
|
October 23, 2013
Pharmacometric characterization of efavirenz developmental pharmacokinetics and pharmacogenetics in HIV-infected children
Ahmed Hamed Salem, Courtney V Fletcher, Richard C Brundage
Clinical Pharmacokinetics
|
June 19, 2016
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors
Anthony T Podany, Kimberly K Scarsi, Courtney V Fletcher
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 5, 2009
The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards
Tom Delahunty, Lane Bushman, Brian Robbins, et al.
CNS Drugs
|
August 3, 2002
Clinical implications of CNS penetration of antiretroviral drugs
Heather E Wynn, Richard C Brundage, Courtney V Fletcher
Page
of 17